Nemaura Medical Profit Margin

Nemaura Medical posts a profit margin of 405.33% as of December 2023. That compares with -4938.27% in the prior-year period — up 108.2% year over year. That is above the Healthcare sector average of 14.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Nemaura Medical's profit margin was -4938.27%. The latest reading is 405.33% — a 108.2% year-over-year increase (period ending December 2023). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 14.34% is typical. Nemaura Medical's 405.33% is higher that level. That is roughly 2725.6% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Nemaura Medical's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 405.33% as of December 2023; use YoY and peer views to separate noise from signal.

Context for NMRD's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 14.34%), and (3) consistency with growth and profitability. This page covers the first two; Nemaura Medical's other metric pages and overview cover the third.